To underline the fact that B cell hyperactivation in HIV infection may contribute to increased risk of AIDS-related lymphomas, Breen et al. investigated the correlation between two B-cell stimulatory molecules—soluble CD23 (sCD23) and IL-6 and lymphoma development. This evidence concerns the gene FCER2 and lymphoma.